144 related articles for article (PubMed ID: 12003698)
1. Effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis.
Flack JM
Curr Hypertens Rep; 2002 Jun; 4(3):183-4. PubMed ID: 12003698
[No Abstract] [Full Text] [Related]
2. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials report. The effect of Ramipril versus Amlodipine on renal outcomes in hypertension nephrosclerosis.
Vidt DG
Curr Hypertens Rep; 2001 Oct; 3(5):379-80. PubMed ID: 11551370
[No Abstract] [Full Text] [Related]
4. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
[TBL] [Abstract][Full Text] [Related]
5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
6. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
Toto RD
Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
[TBL] [Abstract][Full Text] [Related]
7. Hypertensive African Americans with kidney disease should seek advice from doctor about blood pressure medication.
Ethn Dis; 2001; 11(1):3-4. PubMed ID: 11289247
[No Abstract] [Full Text] [Related]
8. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.
Norris K; Bourgoigne J; Gassman J; Hebert L; Middleton J; Phillips RA; Randall O; Rostand S; Sherer S; Toto RD; Wright JT; Wang X; Greene T; Appel LJ; Lewis J;
Am J Kidney Dis; 2006 Nov; 48(5):739-51. PubMed ID: 17059993
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drugs and renal protection.
Fukuda M; Usami T; Yoshida A; Kimura G
JAMA; 2003 Mar; 289(9):1102-3; author reply 1103. PubMed ID: 12622571
[No Abstract] [Full Text] [Related]
10. Blacks with hypertension, renal insufficiency, and baseline proteinuria benefit more from ACE inhibition than from calcium channel blockade.
Basile JN
J Clin Hypertens (Greenwich); 2001; 3(5):315-6. PubMed ID: 11675775
[No Abstract] [Full Text] [Related]
11. [Advantages of ramipril/amlodipin fixed combination therapy. When should we use it?].
Simonyi G
Orv Hetil; 2013 Oct; 154(42):1658-64. PubMed ID: 24121218
[TBL] [Abstract][Full Text] [Related]
12. Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial.
Simonyi G
Chin Med J (Engl); 2016 May; 129(10):1224-8. PubMed ID: 27174332
[TBL] [Abstract][Full Text] [Related]
13. [Hypertensive nephrosclerosis].
Fukuda M; Usami T; Kimura G
Nihon Rinsho; 2004 Mar; 62 Suppl 3():357-62. PubMed ID: 15171399
[No Abstract] [Full Text] [Related]
14. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
Trenkwalder P; Schaetzl R; Borbas E; Handrock R; Klebs S
Blood Press Suppl; 2008 Dec; 2():13-21. PubMed ID: 19205092
[TBL] [Abstract][Full Text] [Related]
15. Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Thornley-Brown D; Wang X; Wright JT; Randall OS; Miller ER; Lash JP; Gassman J; Contreras G; Appel LJ; Agodoa LY; Cheek D
Arch Intern Med; 2006 Apr; 166(7):797-805. PubMed ID: 16606818
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.
Douglas JG; Agodoa L
Kidney Int Suppl; 2003 Feb; (83):S74-6. PubMed ID: 12864879
[TBL] [Abstract][Full Text] [Related]
17. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
[TBL] [Abstract][Full Text] [Related]
18. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Lamarre-Cliche M; de Champlain J; Lacourcière Y; Poirier L; Karas M; Larochelle P
Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
[TBL] [Abstract][Full Text] [Related]
19. Comparative Efficacy of Antihypertensive Drugs in Dogs: A Systematic Review.
Choi HI; Kim J; Shin IS; Kim HJ
Top Companion Anim Med; 2022; 50():100674. PubMed ID: 35640871
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB;
JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
